EODData

MEMBERSHIP REGISTER LOG IN

SHE, 301277: Henan Newland Pharmaceutical Co. Ltd. A

30 Jan 2026
LAST:

12.68

CHANGE:
 0.16		OPEN:
12.53		HIGH:
12.77		ASK:
0.00		VOLUME:
3.07M
CHG(%):
1.28		PREV:
12.52		LOW:
12.47		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
30 Jan 2612.5312.7712.4712.683.07M
29 Jan 2612.6612.6612.4412.522.39M
28 Jan 2612.7812.8312.5212.553.28M
27 Jan 2612.8613.0812.6112.863.81M
26 Jan 2612.8613.1812.7713.095.26M
23 Jan 2612.8612.9612.7812.912.76M
22 Jan 2612.7812.8412.6812.792.65M
21 Jan 2612.6712.8312.6212.762.8M
20 Jan 2612.6312.8212.5712.712.72M
19 Jan 2612.5112.6612.4712.592.14M

PROFILE

Name:Henan Newland Pharmaceutical Co. Ltd. A
About:Newland Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China. The company offers pharmaceutical intermediates, including L-4-hydroxyphenylglycine methyl ester, L-hydroxyphenylglycine potassium salt, L-4-hydroxyphenylglycine, and p-Toluenesulfonic acid. It also provides APIs, such as ropivacaine hydrochloride, naphazoline hydrochloride, moxifloxacin hydrochloride, lidocaine hydrochloride, vildagliptin, tadalafil, chlorpheniramine maleate, clopidogrel bisulfate, lidocaine, gatifloxacin, febuxostat, esomeprazole sodium, and esomeprazole magnesium. The company was formerly known as Henan Newland Pharmaceutical Co., Ltd. and changed its name to Newland Pharmaceutical Co., Ltd. in June 2023. Newland Pharmaceutical Co., Ltd. was founded in 2005 and is based in Changge City, China.
Sector:Healthcare
Address:East side of the southern section of Weiwu Road, Changge City, China, 461500
Website:https://www.newlandpharma.com
ISIN:CNE1000065K2

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:37.44 
Price to Sales:7.01 
Price to Book:3.09 
Profit Margin:0.18 
Operating Margin:0.13 
Return on Assets:0.05 
Return on Equity:0.08 
DivYield:0.02 
Div/Share:0.29 
Revenue:670.43M 
EBITDA:162.79M 
Shares:392.08M 
Market Cap:4.972B 

TECHNICAL INDICATORS

MA5:12.740.5%
MA10:12.750.5%
MA20:12.590.8%
MA50:12.303.1%
MA100:12.790.9%
MA200:13.677.8%
STO9:24.24
STO14:21.05
RSI14:55.61
WPR14:-71.93
MTM14:-0.23
ROC14:-0.02 
ATR:0.32 
Week High:13.183.9%
Week Low:12.441.9%
Month High:13.284.7%
Month Low:11.627.8%
Year High:19.7055.4%
Year Low:11.1713.5%
Volatility:10.78 

RECENT SPLITS

Date Ratio
16 Apr 20251.4-1
10 May 20241.4-1
10 May 20231-1

RECENT DIVIDENDS

Date Amount
16 Apr 2025$0.20
10 May 2024$0.10
10 May 2023$0.13
10 Nov 2022$0.04
11 Aug 2022$0.04
12 May 2022$0.04
17 Feb 2022$0.04
11 Nov 2021$0.04
12 Aug 2021$0.04
06 May 2021$0.04